Brief: Chain Bridge I - SEC Filing
Nov 19 (Reuters) - Chain Bridge I CBRG.O :
* CHAIN BRIDGE I - DELISTING NOT EXPECTED TO IMPACT PHYTANIX
BIO
MERGER
Further company coverage: CBRG.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Chain Bridge I
See all newsBrief: Chain Bridge I and CommLoan Sign LOI to Merge, Form Public CRE Fintech Company
Brief: Chain Bridge I - SEC Filing
Brief: Chain Bridge Bancorp Announces Pricing Of Initial Public Offering
Brief: Chain Bridge Bancorp's Current Estimated IPO Price Of Class A Common Stock Will Be $24-$26/Share
Brief: Phytanix Bio to List on Nasdaq Via $58 Mln SPAC Deal